Day One Biopharmaceuticals Announced An Oversubscribed Private Placement Of Gross Proceeds Of Approximately $175M, Offering 10.55M Shares At $14.50 Per Share
Author: Benzinga Newsdesk | July 30, 2024 07:17am
The private placement will be for 10,551,718 shares of common stock at a price of $14.50 per share. In lieu of shares of common stock, certain investors purchased 1,517,241 pre-funded warrants at a purchase price of $14.4999 per pre-funded warrant, which equals the purchase price per share of common stock, less the $0.0001 per share exercise price of each pre-funded warrant. The pre-funded warrants are exercisable at any time after their original issuance and will not expire.
Posted In: DAWN